Biotech

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 11.11.2022.

#HealthcareNews
#ClinicalResearchNews
#PharmaNews
#MedicalNews
#BiotechNews
#LifeSciencesNews
#PharmiwebNews
#lifescience
#career
#news

@biotechday shared
On Nov 10, 2022
Interesting, especially with UC academic workers, including researchers, postdocs and teaching assistants, considering striking … ‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up... https://t.co/dbQsMDePq5 via @statnews
Open
‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

Faculty are struggling to hire postdocs, delaying research projects and pressuring universities to consider improving salaries and benefits as endowments are shrinking.

@pharminews shared
On Nov 7, 2022
Maxwell Biosciences Names Two Biotech Leaders to Its Board of Directors https://t.co/TLVwWYa6Y7 #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/8L9J8OPkHx
Open
Maxwell Biosciences Names Two Biotech Leaders to Its Board of Directors

Maxwell Biosciences Names Two Biotech Leaders to Its Board of Directors

Appointments of Kate McKinley and Douglas S. Boothe bring more than 45 years of collective biotech expertise spanning business development, alliance management, commercialization and global ...

@JohnCendpts shared
On Nov 8, 2022
https://t.co/MFswdeM4kU
Open
Scoop: A SoftBank-backed biotech raises more funds after bagging $100M+ for fungi mining

Scoop: A SoftBank-backed biotech raises more funds after bagging $100M+ for fungi mining

A biotech mining fungi to find new drugs for cancer and infectious diseases is raising another round of financing, Endpoints News has learned. Hexagon Bio has so far raised $67 million in a ...

@MassBioEd shared
On Nov 9, 2022
RT @HalloranConsult: Providing #lifescience #career opportunities is a big part of our mission, so sponsoring @MassBioEd's Champions for Biotechnology Education Awards was a no-brainer. Read more about this inspirational event in our latest press release here: https://t.co/4IsEUJlYsB https://t.co/wsa5u3pPIz
Open
PRESS RELEASE – Halloran Sponsors 2022 Champions for Biotechnology Education Awards

PRESS RELEASE – Halloran Sponsors 2022 Champions for Biotechnology Education Awards

PRESS RELEASE Wednesday, November 9, 2022 – BOSTON, MA Halloran Consulting Group (Halloran) sponsored MassBioEd’s 7th Annual Champions for Biotechnology Halloran Sponsors Champions for ...

@Labiotech_eu shared
On Nov 10, 2022
The Greek startup ResQ Bio is harnessing bacteria to test potential peptide treatments for Alzheimer’s disease and ALS. 👇🏻 #biotech #lifesciences #news https://t.co/NvljvGLdVP
Open
ResQ Biotech is using bacteria to discover Alzheimer’s treatments

ResQ Biotech is using bacteria to discover Alzheimer’s treatments

The Greek startup ResQ Bio is harnessing bacteria to test potential peptide treatments for Alzheimer’s disease and ALS.

@IAmBiotech shared
On Nov 7, 2022
IP Rights are the foundation of innovation in the life science industry. However, the proposed expansion of the TRIPS waiver hurts the bioscience industry and threatens our national security. Learn more in @Delaware_Bio's op-ed. https://t.co/Xjuqq7F00y
Open
Slashing American IP rights will needlessly hurt Delaware's biotech sector | Opinion

Slashing American IP rights will needlessly hurt Delaware's biotech sector | Opinion

Without robust intellectual property protection, American biotech firms — including some in Delaware — won't be able to safely share innovations.

@JohnCendpts shared
On Nov 9, 2022
I always wondered how Mahaffy made it this far. $CLVS now trading around 28 cents https://t.co/2Sp4kuD2F7
Open
Updated: After a tortured run with a weak PARP player and cash fast running out, Clovis signals likely bankruptcy, slashes 115 staffers

Updated: After a tortured run with a weak PARP player and cash fast running out, Clovis signals likely bankruptcy, slashes 115 staffers

Clovis Oncology’s rocky 13-year run from startup developer to commercialization — while surviving accusations of playing fast and loose with the data — may be coming to a close. The ...

@JohnCendpts shared
On Nov 7, 2022
This just in: https://t.co/MC9pfyjoGZ
Open
Lonnie Moulder’s new biotech play grabs $118M, steering into PhIII and more deals

Lonnie Moulder’s new biotech play grabs $118M, steering into PhIII and more deals

Serial biotech entrepreneur Lonnie Moulder has scored some big wins along the way, most notably the $9 billion he racked up selling MGI and Tesaro. And now the lead project he’s helping ...